Literature DB >> 33132147

The role of inflammaging and advanced glycation end products on paratonia in patients with dementia.

Hans Drenth1, Sytse Zuidema2, Ivan Bautmans3, Hans Hobbelen4.   

Abstract

Impaired motor function is a prominent characteristic of aging. Inflammatory processes and oxidative stress from advanced glycation end-products are related to impaired motor function and could plausibly be a contributing factor to the pathogenesis of paratonia, a specific motor disorder in people with dementia. Severe paratonia results in a substantial increase of a caretaker's burden and a decrease in the quality of life. The pathogenesis of paratonia is not well understood, and no effective interventions are available to combat it. Intensive glycaemic control, reducing oxidative stress, possibly combined with a low AGE diet and AGE targeting medication may be the key method for preventing advanced glycation end-product accumulation and reducing the inflammatory burden as well as possibly postponing or preventing paratonia.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advanced glycation end-products; Dementia; Inflammation; Oxidative stress; Paratonia

Mesh:

Substances:

Year:  2020        PMID: 33132147     DOI: 10.1016/j.exger.2020.111125

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  3 in total

Review 1.  Frailty in metabolic syndrome, focusing on nonalcoholic fatty liver disease.

Authors:  Nikolaos D Karakousis; Lampros Chrysavgis; Antonios Chatzigeorgiou; George Papatheodoridis; Evangelos Cholongitas
Journal:  Ann Gastroenterol       Date:  2022-03-25

Review 2.  Muscle Tone Physiology and Abnormalities.

Authors:  Jacky Ganguly; Dinkar Kulshreshtha; Mohammed Almotiri; Mandar Jog
Journal:  Toxins (Basel)       Date:  2021-04-16       Impact factor: 4.546

3.  Skin Autofluorescence, a Noninvasive Biomarker of Advanced Glycation End-products, Is Associated With Frailty: The Rotterdam Study.

Authors:  Komal Waqas; Jinluan Chen; Fernando Rivadeneira; André G Uitterlinden; Trudy Voortman; M Carola Zillikens
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-10-06       Impact factor: 6.591

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.